Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events.
Davis T, Fedorov K, Gregos PS, Shapiro LC, Shastri A, Gritsman K, Shah N, Sica RA, Konopleva M, Feldman E, Mantzaris I, Braunschweig I, Verma A, Cooper D, Kornblum N, Goldfinger M. Davis T, et al. Among authors: sica ra. J Oncol Res Ther. 2023;8(4):10194. doi: 10.29011/2574-710x.10194. Epub 2023 Dec 20. J Oncol Res Ther. 2023. PMID: 39371330 Free PMC article.
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis.
Abbasi A, Peeke S, Shah N, Mustafa J, Khatun F, Lombardo A, Abreu M, Elkind R, Fehn K, de Castro A, Wang Y, Derman O, Nelson R, Uehlinger J, Gritsman K, Sica RA, Kornblum N, Mantzaris I, Shastri A, Janakiram M, Goldfinger M, Verma A, Braunschweig I, Bachier-Rodriguez L. Abbasi A, et al. Among authors: sica ra. J Hematol Oncol. 2020 Jan 3;13(1):1. doi: 10.1186/s13045-019-0838-y. J Hematol Oncol. 2020. PMID: 31900191 Free PMC article.
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort.
Rabinovich E, Pradhan K, Sica RA, Bachier-Rodriguez L, Mantzaris I, Kornblum N, Shastri A, Gritsman K, Goldfinger M, Verma A, Braunschweig I. Rabinovich E, et al. Among authors: sica ra. Exp Hematol Oncol. 2021 Dec 9;10(1):55. doi: 10.1186/s40164-021-00248-9. Exp Hematol Oncol. 2021. PMID: 34886908 Free PMC article.
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N, Konopleva M, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. Levitz D, et al. Among authors: sica ra. Clin Cancer Res. 2023 Aug 1;29(15):2774-2780. doi: 10.1158/1078-0432.CCR-23-0842. Clin Cancer Res. 2023. PMID: 37341641
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
Hammami MB, Verceles JA, Goldfinger M, Shah N, Sica RA, Mantzaris I, Kornblum N, Konopleva M, Shastri A, Shapiro LC, Feldman EJ, Gritsman K, Verma A, Cooper DL. Hammami MB, et al. Among authors: sica ra. Transplant Cell Ther. 2024 May;30(5):544.e1-544.e8. doi: 10.1016/j.jtct.2024.02.020. Epub 2024 Feb 28. Transplant Cell Ther. 2024. PMID: 38417677
Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D, Kornblum N, Derman O, Bachier-Rodriguez L, Sica RA, Shastri A, Janakiram M, Verma A, Braunschweig I, Mantzaris I. Adrianzen Herrera D, et al. Among authors: sica ra. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):516-521. doi: 10.1016/j.clml.2019.05.002. Epub 2019 May 13. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31227357
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.
Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. Gonzalez-Lugo JD, et al. Among authors: sica ra. Br J Haematol. 2020 Aug;190(3):e130-e133. doi: 10.1111/bjh.16906. Epub 2020 Jun 24. Br J Haematol. 2020. PMID: 32479664 Free PMC article. No abstract available.
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.
Thakkar A, Cui Z, Peeke SZ, Shah N, Pradhan K, Lombardo A, Khatun F, Mustafa J, De Castro A, Gillick K, Joseph F, Naik A, Rahman S, D'Aiello A, Elkind R, Sakalian S, Fehn K, Wright K, Abreu M, Townsend-Nugent L, Chambers N, Mathew R, Binakaj D, Nelson R, Palesi C, Paroder M, Uehlinger J, Wang Y, Shi Y, Zang X, Wang H, Nishimura C, Ren X, Steidl UG, Gritsman K, Janakiram M, Kornblum N, Derman O, Mantzaris I, Shastri A, Bartash R, Puius Y, McCort M, Goldfinger M, Bachier-Rodriguez L, Verma A, Braunschweig I, Sica RA. Thakkar A, et al. Among authors: sica ra. Stem Cell Investig. 2021 Sep 6;8:18. doi: 10.21037/sci-2021-008. eCollection 2021. Stem Cell Investig. 2021. PMID: 34631871 Free PMC article.
Efficacy and safety of CAR-T cell therapy in minorities.
Thakkar A, Abreu M, Pradhan K, Sica RA, Shastri A, Kornblum N, Shah N, Mantzaris I, Gritsman K, Feldman E, Elkind R, Green-Lorenzen S, Verma A, Braunschweig I, Goldfinger M. Thakkar A, et al. Among authors: sica ra. Bone Marrow Transplant. 2022 Jul;57(7):1187-1190. doi: 10.1038/s41409-022-01670-1. Epub 2022 Apr 28. Bone Marrow Transplant. 2022. PMID: 35484206 No abstract available.
45 results